Heal DJ - Search Results

1

Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder.

Heal DJ, Gosden J, Smith SL. Heal DJ, et al. Adv Pharmacol. 2024;99:251-286. doi: 10.1016/bs.apha.2023.10.002. Epub 2023 Oct 25. Adv Pharmacol. 2024. PMID: 38467483 Review.

2

Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.

Heal DJ, Gosden J, Smith SL, Atterwill CK. Heal DJ, et al. Neuropharmacology. 2023 Mar 1;225:109375. doi: 10.1016/j.neuropharm.2022.109375. Epub 2022 Dec 16. Neuropharmacology. 2023. PMID: 36529260 Free article. Review.

3

Psychedelics: Threshold of a Therapeutic Revolution.

Heal DJ, Smith SL, Belouin SJ, Henningfield JE. Heal DJ, et al. Neuropharmacology. 2023 Sep 15;236:109610. doi: 10.1016/j.neuropharm.2023.109610. Epub 2023 May 27. Neuropharmacology. 2023. PMID: 37247807 Free article.

4

Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.

Stanford SC, Heal DJ. Stanford SC, et al. Among authors: heal dj. Handb Exp Pharmacol. 2023 Jul 27. doi: 10.1007/164_2023_675. Online ahead of print. Handb Exp Pharmacol. 2023. PMID: 37495853

5

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.

Henningfield JE, Ashworth J, Heal DJ, Smith SL. Henningfield JE, et al. Among authors: heal dj. J Psychopharmacol. 2023 Jan;37(1):33-44. doi: 10.1177/02698811221140004. Epub 2023 Jan 1. J Psychopharmacol. 2023. PMID: 36588452

6

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.

Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. Henningfield JE, et al. Among authors: heal dj. Neuropharmacology. 2022 Nov 1;218:109220. doi: 10.1016/j.neuropharm.2022.109220. Epub 2022 Aug 17. Neuropharmacology. 2022. PMID: 35987353 Free article. Review.

7

New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development.

Heal DJ, Gosden J, Smith SL. Heal DJ, et al. Curr Top Behav Neurosci. 2022;57:79-126. doi: 10.1007/7854_2022_332. Curr Top Behav Neurosci. 2022. PMID: 35507283 Review.

8

Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence.

Gray RA, Heal DJ, Maguire DR, Gerak LR, Javors MA, Smith S, France CP. Gray RA, et al. Among authors: heal dj. J Pharmacol Exp Ther. 2022 Jul;382(1):54-65. doi: 10.1124/jpet.121.000988. Epub 2022 Apr 30. J Pharmacol Exp Ther. 2022. PMID: 35489780

9

Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats.

Synan C, Bowen C, Heal DJ, Froger-Colléaux C, Beardsley PM, Dedic N, Hopkins SC, Campbell U, Koblan KS. Synan C, et al. Among authors: heal dj. Drug Alcohol Depend. 2022 Feb 1;231:109261. doi: 10.1016/j.drugalcdep.2021.109261. Epub 2021 Dec 31. Drug Alcohol Depend. 2022. PMID: 35033729 Free article.

10

What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.

Heal DJ, Gosden J. Heal DJ, et al. Int J Obes (Lond). 2022 Apr;46(4):677-695. doi: 10.1038/s41366-021-01032-9. Epub 2022 Jan 7. Int J Obes (Lond). 2022. PMID: 34992243 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page